Papers

1

Total Citations

36

H-Index

1

About

Kung‐I Feng is a pharmaceutical scientist whose research focuses on the biopharmaceutical characterization of poorly soluble compounds, particularly through the lens of intestinal media composition and solubility enhancement. His most-cited work, a 2017 study on the effect of simulated intestinal media composition on solubility, has garnered 36 citations, underscoring its relevance to drug formulation and absorption science. Feng’s major contribution lies in systematically applying design of experiments (DoE) to unravel how variations in intestinal fluid components—such as bile salts and phospholipids—impact the dissolution behavior of challenging drug candidates. This work provides a robust framework for predicting in vivo performance, bridging a critical gap between laboratory testing and clinical outcomes. By advancing methodologies for solubility assessment, Feng has equipped researchers with tools to optimize oral drug delivery, particularly for compounds with low aqueous solubility. His research is instrumental for students and scientists navigating the complexities of gastrointestinal drug absorption, offering both practical insights and a rigorous experimental approach that enhances the predictability of preclinical studies.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments
36 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago